The histone deacetylase inhibitor trichostatin a has genotoxic effects in human lymphoblasts in vitro.

Histone deacetylase inhibitors (HDACi) are a class of putative chemotherapeutic agents for which the mechanism of toxicity has not been fully identified. To explore the possibility that HDACi are genotoxic, human TK6 lymphoblastoid cells were exposed to trichostatin A (TSA) and genetic damage was measured. TSA caused a dose-dependent increase of G1-arrested cells at 24 h that correlated with increasing levels of p21 and apoptosis. Significantly elevated frequencies of structural chromosomal aberrations in cells exposed to TSA were observed using both the kinetochore-antibody micronucleus assay and nonbanding metaphase chromosome analysis. Increased tail intensities, indicative of elevated levels of DNA damage, were observed using the alkaline comet assay. Elevated levels of phosphorylated histone gammaH2AX protein were observed as early as 3 h following TSA exposure and peaked at 12 h for 200nM TSA. Significant levels of aneuploidy at the 200nM TSA dose were observed using metaphase analysis, but interestingly, kinetochore-positive micronuclei were not detected at any dose using the kinetochore micronucleus assay, suggesting that TSA induces aneuploidy via a nondisjunction event rather than chromosome lagging. Increases in chromosomal loss and breakage were observed using simultaneous FISH metaphase analysis of chromosomes 5, 7, 8, and 21, consistent with data obtained from the micronucleus and metaphase chromosome analyses. We conclude that TSA is both a clastogen and aneugen in the TK6 cell line and propose that the observed cytostatic and apoptotic properties of TSA may partially be due to this genotoxicity.

[1]  D. Cimini,et al.  Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. , 2003, Molecular biology of the cell.

[2]  R. Hayes,et al.  Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. , 1998, Cancer research.

[3]  P. Hasty,et al.  Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor , 2005, Nucleic acids research.

[4]  Christophe E. Redon,et al.  Characteristics of γ-H2AX foci at DNA double-strand breaks sites , 2003 .

[5]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.

[6]  A. Collins.  The Comet Assay , 2002 .

[7]  M. Yao,et al.  Role of Histone Deacetylation in Developmentally Programmed DNA Rearrangements in Tetrahymena thermophila , 2002, Eukaryotic Cell.

[8]  B. Turner,et al.  Transient Inhibition of Histone Deacetylation Alters the Structural and Functional Imprint at Fission Yeast Centromeres , 1997, Cell.

[9]  E. Sausville,et al.  Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma. , 2005, Neoplasia.

[10]  S. Grewal,et al.  Histone deacetylase homologs regulate epigenetic inheritance of transcriptional silencing and chromosome segregation in fission yeast. , 1998, Genetics.

[11]  Ricky W Johnstone,et al.  Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? , 2003, Cancer cell.

[12]  T. Fojo,et al.  Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. , 2002, Molecular cancer therapeutics.

[13]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[14]  Gabriele Müller,et al.  Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin , 2003, Journal of Cell Science.

[15]  A. Collins.  The comet assay. Principles, applications, and limitations. , 2002, Methods in molecular biology.

[16]  Taddel Angela,et al.  Reversible Disruption of pericentric Heterochromatin and Centromere Function by Inhibiting Deacetylases , 2001 .

[17]  K. Ekwall.  The roles of histone modifications and small RNA in centromere function , 2004, Chromosome Research.

[18]  J D Tucker,et al.  Identification of aneuploidy‐inducing agents using cytokinesis‐blocked human lymphocytes and an antikinetochore antibody , 1989, Environmental and molecular mutagenesis.

[19]  C. Benz,et al.  Clinical development of histone deacetylase inhibitors as anticancer agents. , 2005, Annual review of pharmacology and toxicology.

[20]  A. Nussenzweig,et al.  Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. , 2003, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[21]  H. White,et al.  Some heteroskedasticity-consistent covariance matrix estimators with improved finite sample properties☆ , 1985 .

[22]  D. Fairlie,et al.  Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Luoping Zhang,et al.  Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes. , 1998, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.